BETHANY PETERSON: Open Payments
NPI 1144827957 · COLUMBUS, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$740 in 28 payments from 12 companies in 2025. Trend: 2023 $977 · 2024 $665 · 2025 $740
Food & beverage: $738Education: $2
| Company | Payments | Amount |
|---|---|---|
| AKEBIA THERAPEUTICS INC | 5 | $228 |
| AstraZeneca Pharmaceuticals LP | 6 | $164 |
| Mallinckrodt Hospital Products Inc. | 3 | $81 |
| SCPHARMACEUTICALS INC. | 3 | $64 |
| Otsuka America Pharmaceutical, Inc. | 2 | $53 |
| Calliditas Therapeutics US Inc. | 2 | $51 |
| Novo Nordisk Inc | 2 | $35 |
| Aurinia Pharma U.S., Inc. | 1 | $18 |
| Novartis Pharmaceuticals Corporation | 1 | $17 |
| Fresenius USA Manufacturing, Inc. | 1 | $16 |
Products named: Vafseo, FARXIGA, ACTHAR, Auryxia, LOKELMA, FUROSCIX, JYNARQUE, TARPEYO.
Industry payments across GA — which companies pay providers there.
